491 related articles for article (PubMed ID: 19354203)
1. In silico fragment screening by replica generation (FSRG) method for fragment-based drug design.
Fukunishi Y; Mashimo T; Orita M; Ohno K; Nakamura H
J Chem Inf Model; 2009 Apr; 49(4):925-33. PubMed ID: 19354203
[TBL] [Abstract][Full Text] [Related]
2. In-silico drug screening method based on the protein-compound affinity matrix using the factor selection technique.
Murali S; Hojo S; Tsujishita H; Nakamura H; Fukunishi Y
Eur J Med Chem; 2007 Jul; 42(7):966-76. PubMed ID: 17307278
[TBL] [Abstract][Full Text] [Related]
3. Novel technologies for virtual screening.
Lengauer T; Lemmen C; Rarey M; Zimmermann M
Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
[TBL] [Abstract][Full Text] [Related]
4. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
Mizutani MY; Itai A
J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
[TBL] [Abstract][Full Text] [Related]
5. A new method for in-silico drug screening and similarity search using molecular dynamics maximum volume overlap (MD-MVO) method.
Fukunishi Y; Nakamura H
J Mol Graph Model; 2009 Jan; 27(5):628-36. PubMed ID: 19046907
[TBL] [Abstract][Full Text] [Related]
6. An efficient in silico screening method based on the protein-compound affinity matrix and its application to the design of a focused library for cytochrome P450 (CYP) ligands.
Fukunishi Y; Hojo S; Nakamura H
J Chem Inf Model; 2006; 46(6):2610-22. PubMed ID: 17125201
[TBL] [Abstract][Full Text] [Related]
7. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
Schlosser J; Rarey M
J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
[TBL] [Abstract][Full Text] [Related]
8. Selection of in silico drug screening results by using universal active probes (UAPs).
Fukunishi Y; Ohno K; Orita M; Nakamura H
J Chem Inf Model; 2010 Jul; 50(7):1233-40. PubMed ID: 20578712
[TBL] [Abstract][Full Text] [Related]
9. Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score.
Chen G; Zheng S; Luo X; Shen J; Zhu W; Liu H; Gui C; Zhang J; Zheng M; Puah CM; Chen K; Jiang H
J Comb Chem; 2005; 7(3):398-406. PubMed ID: 15877468
[TBL] [Abstract][Full Text] [Related]
10. In silico fragment-based discovery of indolin-2-one analogues as potent DNA gyrase inhibitors.
Oblak M; Grdadolnik SG; Kotnik M; Jerala R; Filipic M; Solmajer T
Bioorg Med Chem Lett; 2005 Dec; 15(23):5207-10. PubMed ID: 16203145
[TBL] [Abstract][Full Text] [Related]
11. Strategies for developing protein tyrosine phosphatase inhibitors.
Tautz L; Mustelin T
Methods; 2007 Jul; 42(3):250-60. PubMed ID: 17532512
[TBL] [Abstract][Full Text] [Related]
12. Automatic and efficient decomposition of two-dimensional structures of small molecules for fragment-based high-throughput docking.
Kolb P; Caflisch A
J Med Chem; 2006 Dec; 49(25):7384-92. PubMed ID: 17149868
[TBL] [Abstract][Full Text] [Related]
13. In silico fragment-based discovery of DPP-IV S1 pocket binders.
Rummey C; Nordhoff S; Thiemann M; Metz G
Bioorg Med Chem Lett; 2006 Mar; 16(5):1405-9. PubMed ID: 16321524
[TBL] [Abstract][Full Text] [Related]
14. Ligand-target interaction-based weighting of substructures for virtual screening.
Crisman TJ; Sisay MT; Bajorath J
J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
[TBL] [Abstract][Full Text] [Related]
15. Considerations in compound database preparation--"hidden" impact on virtual screening results.
Knox AJ; Meegan MJ; Carta G; Lloyd DG
J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
[TBL] [Abstract][Full Text] [Related]
16. Strategy for discovering chemical inhibitors of human cyclophilin a: focused library design, virtual screening, chemical synthesis and bioassay.
Li J; Zhang J; Chen J; Luo X; Zhu W; Shen J; Liu H; Shen X; Jiang H
J Comb Chem; 2006; 8(3):326-37. PubMed ID: 16677001
[TBL] [Abstract][Full Text] [Related]
17. In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors.
Zhang YJ; Wang Z; Sprous D; Nabioullin R
Bioorg Med Chem Lett; 2006 Feb; 16(3):525-8. PubMed ID: 16288866
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
19. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
[TBL] [Abstract][Full Text] [Related]
20. Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.
Baurin N; Aboul-Ela F; Barril X; Davis B; Drysdale M; Dymock B; Finch H; Fromont C; Richardson C; Simmonite H; Hubbard RE
J Chem Inf Comput Sci; 2004; 44(6):2157-66. PubMed ID: 15554686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
